Fenofibrate reduces glucose-induced barrier dysfunction in feline enteroids

被引:1
作者
Crawford, Charles K. [1 ]
Beltran, Aeelin [1 ]
Castillo, Diego [1 ]
Matloob, Muhammad S. [1 ]
Uehara, Mimoli E. [1 ]
Quilici, Mary L. [1 ]
Cervantes, Veronica Lopez [1 ]
Kol, Amir [1 ]
机构
[1] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA
关键词
PROTEIN-KINASE-C; INTESTINAL PERMEABILITY; PPAR-ALPHA; DIABETES-MELLITUS; ACTIVATION; PHYSIOLOGY; ORGANOIDS; JUNCTIONS; MANNITOL; CHILDREN;
D O I
10.1038/s41598-023-49874-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Diabetes mellitus (DM) is a common chronic metabolic disease in humans and household cats that is characterized by persistent hyperglycemia. DM is associated with dysfunction of the intestinal barrier. This barrier is comprised of an epithelial monolayer that contains a network of tight junctions that adjoin cells and regulate paracellular movement of water and solutes. The mechanisms driving DM-associated barrier dysfunction are multifaceted, and the direct effects of hyperglycemia on the epithelium are poorly understood. Preliminary data suggest that fenofibrate, An FDA-approved peroxisome proliferator-activated receptor-alpha (PPAR alpha) agonist drug attenuates intestinal barrier dysfunction in dogs with experimentally-induced DM. We investigated the effects of hyperglycemia-like conditions and fenofibrate treatment on epithelial barrier function using feline intestinal organoids. We hypothesized that glucose treatment directly increases barrier permeability and alters tight junction morphology, and that fenofibrate administration can ameliorate these deleterious effects. We show that hyperglycemia-like conditions directly increase intestinal epithelial permeability, which is mitigated by fenofibrate. Moreover, increased permeability is caused by disruption of tight junctions, as evident by increased junctional tortuosity. Finally, we found that increased junctional tortuosity and barrier permeability in hyperglycemic conditions were associated with increased protein kinase C-alpha (PKC alpha) activity, and that fenofibrate treatment restored PKC alpha activity to baseline levels. We conclude that hyperglycemia directly induces barrier dysfunction by disrupting tight junction structure, a process that is mitigated by fenofibrate. We further propose that counteracting modulation of PKC alpha activation by increased intracellular glucose levels and fenofibrate is a key candidate regulatory pathway of tight junction structure and epithelial permeability.
引用
收藏
页数:11
相关论文
共 64 条
  • [1] Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs
    Ali, Ferhana Y.
    Armstrong, Paul C. J.
    Dhanji, Al-Rehan A.
    Tucker, Arthur T.
    Paul-Clark, Mark J.
    Mitchell, Jane A.
    Warner, Timothy D.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (05) : 706 - 711
  • [2] Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus
    Alt, Nina
    Kley, Saskia
    Haessig, Michael
    Reusch, Claudia E.
    [J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2007, 230 (07): : 1011 - 1017
  • [3] Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept
    Amar, J.
    Serino, M.
    Lange, C.
    Chabo, C.
    Iacovoni, J.
    Mondot, S.
    Lepage, P.
    Klopp, C.
    Mariette, J.
    Bouchez, O.
    Perez, L.
    Courtney, M.
    Marre, M.
    Klopp, P.
    Lantieri, O.
    Dore, J.
    Charles, M. A.
    Balkau, B.
    Burcelin, R.
    [J]. DIABETOLOGIA, 2011, 54 (12) : 3055 - 3061
  • [4] PPARα contributes to colonic protection in mice with DSS-induced colitis
    Azuma, Yasu-Taka
    Nishiyama, Kazuhiro
    Matsuo, Yukiko
    Kuwamura, Mitsuru
    Morioka, Ai
    Nakajima, Hidemitsu
    Takeuchi, Tadayoshi
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (10) : 1261 - 1267
  • [5] Fenofibrate inhibits intestinal Cl- secretion by blocking basolateral KCNQ1 K+ channels
    Bajwa, Poonam J.
    Alioua, Abderrahmane
    Lee, Jimmy W.
    Straus, Daniel S.
    Toro, Ligia
    Lytle, Christian
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 293 (06): : G1288 - G1299
  • [6] Banfield Pet Hospital, 2016, STATE PET HLTH 2016
  • [7] New ways of thinking about (and teaching about) intestinal epithelial function
    Barrett, Kim E.
    [J]. ADVANCES IN PHYSIOLOGY EDUCATION, 2008, 32 (01) : 25 - 34
  • [8] Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
    Braissant, O
    Foufelle, F
    Scotto, C
    Dauca, M
    Wahli, W
    [J]. ENDOCRINOLOGY, 1996, 137 (01) : 354 - 366
  • [9] Genome-wide analysis of PPARα activation in murine small intestine
    Bunger, Meike
    van den Bosch, Heleen M.
    van der Meijde, Jolanda
    Kersten, Sander
    Hooiveld, Guido J. E. J.
    Muller, Michael
    [J]. PHYSIOLOGICAL GENOMICS, 2007, 30 (02) : 192 - 204
  • [10] CINGULIN, A NEW PERIPHERAL COMPONENT OF TIGHT JUNCTIONS
    CITI, S
    SABANAY, H
    JAKES, R
    GEIGER, B
    KENDRICKJONES, J
    [J]. NATURE, 1988, 333 (6170) : 272 - 276